Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.32
(
-1.72%
)
Bitcoin
75,499.12
(
-0.46%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biocqr post# 165812

Tuesday, 09/10/2013 3:49:32 PM

Tuesday, September 10, 2013 3:49:32 PM

Post# of 257644
PTLA’s BLA submission for PRT4445 in 2015 will include data on the reversibility of all FXa inhibitors* as well as Lovenox and other LMWH’s. (Source: Today’s MS webcast.) Good luck with that, LOL; my opinion in #msg-91053501 remains unchanged.

*Xarelto, Elliquis, Edoxaban, Betrixaban.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today